CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
出版年份 2021 全文链接
标题
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
作者
关键词
-
出版物
Pharmaceutics
Volume 14, Issue 1, Pages 73
出版商
MDPI AG
发表日期
2021-12-29
DOI
10.3390/pharmaceutics14010073
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody Opsonization of a TLR9 Agonist–Containing Virus-like Particle Enhances In Situ Immunization
- (2020) Caitlin D. Lemke-Miltner et al. JOURNAL OF IMMUNOLOGY
- A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo
- (2020) Tete Li et al. Frontiers in Pharmacology
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- 1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
- (2020) H. Babiker et al. ANNALS OF ONCOLOGY
- In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
- (2020) Yinwen Cheng et al. Journal for ImmunoTherapy of Cancer
- Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA
- (2019) Jiana Jiang et al. Nanoscale Research Letters
- B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
- (2019) Johannes Griss et al. Nature Communications
- The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
- (2019) Zuzanna Urban-Wojciuk et al. Frontiers in Immunology
- Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy
- (2018) Daqing Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Toll-like receptor 9 activation by CpG oligodeoxynucleotide�7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway
- (2018) Sujuan Yuan et al. Oncology Letters
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase 2 IMPULSE study
- (2018) M Thomas et al. ANNALS OF ONCOLOGY
- Simulation of Stimulation: Cytokine Dosage and Cell Cycle Crosstalk Driving Timing-Dependent T Cell Differentiation
- (2018) Matteo Barberis et al. Frontiers in Physiology
- The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia
- (2017) Chunyan Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma
- (2017) Qing Ma et al. JOURNAL OF IMMUNOTHERAPY
- Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
- (2017) Shu Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
- (2017) L Huang et al. ONCOGENE
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- Interleukin-4 Supports the Suppressive Immune Responses Elicited by Regulatory T Cells
- (2017) Wei-Cheng Yang et al. Frontiers in Immunology
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
- (2016) I. Azzaoui et al. BLOOD
- Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+T cells
- (2016) Shu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice
- (2016) Wei Sun et al. Journal of Cancer
- MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside
- (2015) Burghardt Wittig et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
- (2015) Manuel Schmidt et al. Nucleic Acid Therapeutics
- CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway
- (2015) Rebekah L. Browning et al. Oncotarget
- Abstract A56: Intratumoral injection of IMO-2055, a novel Toll-like receptor 9 agonist, with ipilimumab induces a systemic tumor-specific immune response
- (2015) Daqing Wang et al. Cancer Immunology Research
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
- (2015) Kristina Iribarren et al. OncoImmunology
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
- (2015) Svetlana Karakhanova et al. OncoImmunology
- Cancer vaccine adjuvants – recent clinical progress and future perspectives
- (2014) Abid H. Banday et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
- (2014) Li-Sheng Chang et al. Molecular Cancer
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Genuine Immunomodulation With dSLIM
- (2014) Kerstin Kapp et al. Molecular Therapy-Nucleic Acids
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas
- (2013) L Heller et al. CANCER GENE THERAPY
- The Role and Regulation of Human Th17 Cells in Tumor Immunity
- (2012) Jian Ye et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
- (2011) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
- (2011) Clive S. Zent et al. LEUKEMIA & LYMPHOMA
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
- (2011) Kevin M. Hart et al. Frontiers in Immunology
- Differential Effects of P-Class Versus Other CpG Oligodeoxynucleotide Classes on the Impaired Innate Immunity of Plasmacytoid Dendritic Cells in HIV Type 1 Infection
- (2010) Norbert Donhauser et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
- (2010) X. Liang et al. BLOOD
- Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity
- (2010) Petra Cerkovnik et al. BMC IMMUNOLOGY
- Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors
- (2010) Fu Qiu et al. Innate Immunity
- A Myeloid Cell Population Induced by Freund Adjuvant Suppresses T-cell−mediated Antitumor Immunity
- (2010) Zibing Wang et al. JOURNAL OF IMMUNOTHERAPY
- Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
- (2010) Youn H. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
- (2009) Kaley D. Wilson et al. ADVANCED DRUG DELIVERY REVIEWS
- Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles
- (2009) Padma Malyala et al. ADVANCED DRUG DELIVERY REVIEWS
- The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity
- (2009) Sakulrat Rattanakiat et al. BIOMATERIALS
- Type 17 CD8+ T cells display enhanced antitumor immunity
- (2009) C. S. Hinrichs et al. BLOOD
- Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model
- (2009) Christian Ginzkey et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
- (2009) John A. Thompson et al. Clinical Genitourinary Cancer
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors
- (2009) Petra Cerkovnik et al. Innate Immunity
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impact of Secondary Structure of Toll-Like Receptor 9 Agonists on Interferon Alpha Induction
- (2008) D. Yu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells
- (2008) K. Gotoh et al. BLOOD
- Tumor-specific Th17-polarized cells eradicate large established melanoma
- (2008) P. Muranski et al. BLOOD
- Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
- (2008) B. G. Molenkamp et al. CLINICAL CANCER RESEARCH
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started